In Conversation

In healthcare, "profitable" is a taboo word. However, if it is not profitable, it is not sustainable

Merck’s heritage in Spain is a heritage of innovation and the company has chosen to build on that historic presence

We utilised a conceptual decision-making framework [to respond to COVID-19]; economy and health are not opposing terms, they are complimentary. Our goal was to boost economic…

Ultimately, CataloniaBio & HealthTech wishes to position Catalonia as one of the top health hubs in the world

The Spanish ecosystem knows the recipe and understands that there must be a permanent dialogue between the administration, patients, HCPs, academia, regulatory authorities, and industry

Four years ago, a molecule discovered and designed by scientists in Alcobendas for the treatment of metastatic breast cancer was approved by regulatory agencies across the…

I see my staff as a family; together, engaged, motivated and driven by our mission to help patients overcome very serious diseases

I hope that the COVID-19 pandemic has foregrounded the value that [the generics] industry can bring

Spanish biotechnology is very strong and internationally competitive in many fields, including among others biocatalysis, nanobiotechnology, microbial biotechnology and cancer research

Lilly enters 2022 with significant momentum after a successful 2021 and an unprecedentedly strong pipeline

In some ways, the case of remdesivir resembles what happened with sofosbuvir, where initial concerns were raised about the price tag but history proved that the…

The main reason for the company’s financial success is our driven and loyal workforce which has gone above and beyond during the COVID-19 crisis, in addition…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here